Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Adoption of ASU No. 2016-13	Common stock and additional paid-in capital	Retained earnings	Retained earnings Adoption of ASU No. 2016-13	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022			11,045,186
Balance at beginning of period at Dec. 31, 2022	$ 228,923	$ (6,277)	$ 68,545	$ 204,343	$ (6,277)	$ (43,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,839			22,839
Net unrealized gain (loss) on securities available for sale, net of tax	(9,134)					(9,134)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	6					6
Net unrealized (loss) gain on hedging derivative instruments	866					866
Comprehensive income (loss)	14,577			22,839		(8,262)
Cash dividends declared	(11,525)			(11,525)
Equity compensation expense	607		$ 607
Payment to repurchase common stock (in shares)			(12,629)
Payment to repurchase common stock	(248)			(248)
Issuance of restricted stock (in shares)			33,610
Proceeds from sale of common stock (in shares)			23,123
Proceeds from sale of common stock	$ 608		$ 608
Ending balance (in shares) at Sep. 30, 2023	11,089,290		11,089,290
Balance at end of period at Sep. 30, 2023	$ 226,665		$ 69,760	209,132		(52,227)
Beginning balance (in shares) at Jun. 30, 2023			11,081,800
Balance at beginning of period at Jun. 30, 2023	232,003		$ 69,351	205,539		(42,887)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,474			7,474
Net unrealized gain (loss) on securities available for sale, net of tax	(10,071)					(10,071)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	1					1
Net unrealized (loss) gain on hedging derivative instruments	730					730
Comprehensive income (loss)	(1,866)			7,474		(9,340)
Cash dividends declared	(3,881)			(3,881)
Equity compensation expense	210		$ 210
Issuance of restricted stock (in shares)			(250)
Proceeds from sale of common stock (in shares)			7,740
Proceeds from sale of common stock	$ 199		$ 199
Ending balance (in shares) at Sep. 30, 2023	11,089,290		11,089,290
Balance at end of period at Sep. 30, 2023	$ 226,665		$ 69,760	209,132		(52,227)
Beginning balance (in shares) at Dec. 31, 2023	11,098,057		11,098,057
Balance at beginning of period at Dec. 31, 2023	$ 243,079		$ 70,182	211,925		(39,028)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	19,763			19,763
Net unrealized gain (loss) on securities available for sale, net of tax	5,181					5,181
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	7					7
Net unrealized (loss) gain on hedging derivative instruments	(436)					(436)
Comprehensive income (loss)	24,515			19,763		4,752
Cash dividends declared	(11,917)			(11,917)
Equity compensation expense	680		$ 680
Payment to repurchase common stock (in shares)			(9,081)
Payment to repurchase common stock	(212)			(212)
Issuance of restricted stock (in shares)			32,859
Proceeds from sale of common stock (in shares)			26,231
Proceeds from sale of common stock	$ 638		$ 638
Ending balance (in shares) at Sep. 30, 2024	11,148,066		11,148,066
Balance at end of period at Sep. 30, 2024	$ 256,783		$ 71,500	219,559		(34,276)
Beginning balance (in shares) at Jun. 30, 2024			11,139,639
Balance at beginning of period at Jun. 30, 2024	244,668		$ 71,053	215,999		(42,384)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,571			7,571
Net unrealized gain (loss) on securities available for sale, net of tax	8,975					8,975
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	2					2
Net unrealized (loss) gain on hedging derivative instruments	(869)					(869)
Comprehensive income (loss)	15,679			7,571		8,108
Cash dividends declared	(4,011)			(4,011)
Equity compensation expense	230		$ 230
Payment to repurchase common stock (in shares)			(200)
Proceeds from sale of common stock (in shares)			8,627
Proceeds from sale of common stock	$ 217		$ 217
Ending balance (in shares) at Sep. 30, 2024	11,148,066		11,148,066
Balance at end of period at Sep. 30, 2024	$ 256,783		$ 71,500	$ 219,559		$ (34,276)